Illumina

$300.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$24.45 (-7.58%) Today
+$1.98 (+0.66%) As of 7:43 AM EDT after-hours

Why Robinhood?

You can buy or sell Illumina and other stocks, options, ETFs, and crypto commission-free!

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Read More The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Employees
7,700
Headquarters
San Diego, California
Founded
1998
Market Cap
43.51B
Price-Earnings Ratio
68.87
Dividend Yield
—
Average Volume
1.63M
High Today
$316.81
Low Today
$293.49
Open Price
$315.91
Volume
5.36M
52 Week High
$404.20
52 Week Low
$196.78

Collections

ILMN News

Benzinga22h

A Look Into Illumina's Price Over Earnings

Looking into the current session, Illumina Inc. (NASDAQ: ILMN) is trading at $311.85, after a 3.29% decrease. Over the past month, the stock decreased by 12.06%
Benzinga22h

ROCE Insights For Illumina

Illumina (NASDAQ: ILMN) posted Q2 earnings of $96.00 million, an increase from Q1 of 49.21%. Sales dropped to $633.00 million, a 26.31% decrease between quarter
BenzingaSep 17

Illumina In Talks To Acquire Cancer Startup Backed By Jeff Bezos, Bill Gates At $8B: Report

A week after filing for an initial public offering with the Securities and Exchange Commission, reports are suggesting that the cancer detection startup Grail I

ILMN Earnings

$0.00
$0.64
$1.29
$1.93
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Oct 22, After Hours

You May Also Like

More ILMN News

BloombergSep 16

Illumina Nears Deal to Buy Health-Care Startup Grail

(Bloomberg) -- Genetic sequencing giant Illumina Inc. is in talks to acquire cancer-detection startup Grail Inc., according to people familiar with the matter.
MarketWatchSep 16

Illumina's stock falls after Bloomberg reports it is considering acquisition of Grail Inc.

Shares of Illumina Inc. ILMN, -7.00% tumbled 6.3% in trading on Wednesday after Bloomberg reported that the company is in talks to acquire Grail Inc., which las
ReutersSep 16

Illumina in talks to buy cancer testing startup Grail: Bloomberg News

FILE PHOTO: A new office building housing genetic research company Illumina is shown in San Diego, California, U.S., May 30, 2018. REUTERS/Mike Blake Illumina i
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.